Andy Page is responsible for setting the commercial strategy to fuel the continued growth trajectory for the company. He has a track record of building and transforming operations and culture, with over 25 years of strategic marketing and general management experience in the Life Science industry spanning biotech, big pharma and and medical technology and devices. After completing a combined honours degree in Pharmacology and Physiology at the University of Leeds, Andy developed his career in commercial operations and has led global, regional and affiliate teams in Europe, Asia Pacific, the Middle East and Africa. He gained senior level experiences at Johnson & Johnson (Janssen and J&J MedTech), Otsuka Pharmaceuticals and Beckley Psytech and concentrates on where and how to create and add value to businesses from pre-clinical development through to reimbursement, access and broad commercialisation. During his career he has worked across multiple therapeutic areas, and most recently as CEO and President of Otsuka Pharmaceutical Europe led the development and commercialisation of assets in oncology, neurology, psychiatry and renal disease areas.